Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lignocaine vs Bupivacaine Infiltration for Postpartum Perineal Pain After Vaginal Delivery With Episiotomy in Primigravidae: A Prospective Randomized, Double-Blind, Clinical Trial

NCT06568289 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT06568289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06568289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lignocaine vs Bupivacaine Infiltration for Postpartum Perineal Pain After Vaginal Delivery With Episiotomy in Primigravidae: A Prospective Randomized, Double-Blind, Clinical Trial
Lead sponsor
Ain Shams University
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2024
Completion date
September 1, 2024
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bupivacaine, episiotomy, lignocaine, postpartum perineal pain, primigravidae, vaginal delivery